These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10989237)

  • 1. Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies.
    Verheul HA; Coelingh-Bennink HJ; Kenemans P; Atsma WJ; Burger CW; Eden JA; Hammar M; Marsden J; Purdie DW
    Maturitas; 2000 Jul; 36(1):1-17. PubMed ID: 10989237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
    Fournier A; Berrino F; Riboli E; Avenel V; Clavel-Chapelon F
    Int J Cancer; 2005 Apr; 114(3):448-54. PubMed ID: 15551359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
    Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone replacement therapy in menopause and risk of breast cancer].
    Clavel-Chapelon F; Hill C
    Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous and exogenous endocrine factors.
    Henderson BE
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):577-98. PubMed ID: 2691490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormones and breast cancer.
    Wile AG; DiSaia PJ
    Am J Surg; 1989 Apr; 157(4):438-42. PubMed ID: 2648885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormonal replacement therapy and breast cancer].
    This P
    Rev Prat; 2005 Feb; 55(4):377-82. PubMed ID: 15828615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.
    Deli T; Orosz M; Jakab A
    Pathol Oncol Res; 2020 Jan; 26(1):63-78. PubMed ID: 30617760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
    Corrao G; Zambon A; Conti V; Nicotra F; La Vecchia C; Fornari C; Cesana G; Contiero P; Tagliabue G; Nappi RE; Merlino L
    Ann Oncol; 2008 Jan; 19(1):150-5. PubMed ID: 17785762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
    Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
    Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of breast cancer.
    Marchant DJ
    Clin Obstet Gynecol; 1982 Jun; 25(2):387-92. PubMed ID: 7105514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
    O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
    J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL; Ingvar C; Bladström A
    Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.